BRD2 and chronic kidney disease: Individuals with schizophrenia showed an increased level of NAT (F (1, 79) = 9.833; p < 0.05, partial η2 = 0.111), more credibility in their NAT (F (1, 79) = 4.348; p < 0.05, partial η2 = 0.052), more EA (F (1, 79) = 6.775; p < 0.05, partial η2 = 0.079), and more CF (F (1, 79) = 6.834; p < 0.05, partial η2 = 0.080) in comparison to individuals with end-stage CKD (for more details, see Table 2).